Performance Measure NQF Endorsed CDC PCNASR/AHA GWTG-Stroke TJC CMS HIQRP AHA Ischemic Stroke Performance Measure New Measure 1 Baseline severity score 2 Coagulopathy reversal o 3 Venous thromboembolism prophylaxis o o o o o 4 Admission unit 5 Dysphagia screen: assessment o o 6 Dysphagia screen: management o o 7 Long-term blood pressure treatment 8 Assessed for rehabilitation 9 Avoid corticosteroids indicates identical measure present in other measurement set; o, analogous but not identical measure present in other measurement set; AHA, American Heart Association; ASA, American Stroke Association; CDC, Centers for Disease Control and Prevention; CMS, Centers for Medicare & Medicaid Services; GWTG-Stroke, Get With The Guidelines Stroke; HIQRP, Hospital Inpatient Quality Reporting Program; ICH, intracerebral hemorrhage; NQF, National Quality Forum; PCNASR, Paul Coverdell National Acute Stroke Registry; and TJC, The Joint Commission. gap remains between many processes of care derived from evi- dence-based guidelines and performance metrics that meet the various criteria such as feasibility, interpretability, and ability to be reliably and directly measured in the context of current stroke care. Consequently, most if not all current and endorsed ICH and ischemic stroke performance measures target pro- cesses of care. The writing group felt that as the field of quality assessment and performance measurement moves forward in stroke, priority should be placed on piloting outcome assess- ment for various performance measures with the goal of future transition from process measurement to patient-based outcome measurement. What follows is a brief discussion of each per- formance measure with a focus on unique or potentially con- troversial issues in its development. The recommendation for a baseline severity score in all patients with acute ICH was new in the 2015 AHA/ASA ICH guidelines and was considered as a metric for Comprehensive Stroke Centers in the 2011 AHA/ASA recommendations. 